Fennec Pharmaceuticals Inc. ( FENC) - Key Metrics
FENC Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $0.45 | -$0.17 | ? | ? |
| 2025Q3 | $0.45 | -$0.02 | $0.05 | $0.05 |
| 2025Q2 | $0.35 | -$0.11 | -$0.13 | -$0.13 |
| 2025Q1 | $0.32 | -$0.04 | -$0.16 | -$0.16 |
FENC Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -11.49 |
| 2025Q3 | ? | -102.29 |
| 2025Q2 | ? | -18.21 |
| 2025Q1 | ? | -36.04 |
FENC Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | 1.13% | ? |
| 2025Q4 | -2.48% | ? |
| 2025Q3 | 0.57% | ? |
| 2025Q2 | -1.61% | ? |
| 2025Q1 | -2.57% | ? |
FENC
Price: $9.99
52 week price:
Earnings Per Share: -0.29 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 138134
Ebitda: -2.2 millionMarket Capitalization: 305.8 million